An Open Trial of Metacognitive Remediation Therapy and Pharmacotherapy to Promote Smoking Cessation among Individuals with Psychotic-Spectrum Disorders
Table 4
Engagement with MCR-Q and pharmacotherapy and completion of follow-up assessments.
Measure
(%)
Engagement with intervention
MCR-Q
100% of sessions completed
32 (66.7%)
81-99% of sessions completed
2 (4.1%)
50-80% of sessions completed
3 (6.3%)
< 50% of sessions completed
11 (22.9%)
Pharmacotherapy
81-100% of sessions where pharmacotherapy was used